oAlert.pl
WARNING: RECALLED PRODUCT
PL EN

Auroverin MR

The test showed that the release of mebeverine hydrochloride was slower than allowed by quality requirements, which affects the product’s effectiveness and poses a real and direct threat to patients’ health or life. Potential effects: lack of treatment efficacy, possible worsening of symptoms, complications.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

Auroverin MR
Risk Level
Critical
Manufacturer
Aurovitas Pharma Polska sp. z o.o. z siedzibą w Warszawie
Batch Number
EMBCD2064A
EAN Code
05909991340919
Recall Date
22.12.2023
View official statement

Important Information

What You Should Know

Recommendations

Do not use the product from batch EMBCD2064A. Patients should check the batch number of their medicine and, if it matches, return the product to the pharmacy or consult a doctor.

Actions Taken

The distribution of Auroverin MR batch EMBCD2064A was suspended nationwide and the decision was given immediate enforceability after negative quality test results from the National Medicines Institute...

Need Help?

If you feel unwell after consuming this product, contact your doctor or call the poison control center.

FAQ

Frequently Asked Questions

Is this product safe to consume?
No. This product has been recalled due to: The test showed that the release of mebeverine hydrochloride was slower than allowed by quality requirements, which affects the product’s effectiveness and poses a real and direct threat to patients’ health or life. Potential effects: lack of treatment efficacy, possible worsening of symptoms, complications.
What should I do if I already bought this?
Stop using the product immediately. Return it to the store for a full refund. If you consumed it and feel unwell, contact your doctor.
Which batches are affected?
Affected batch numbers: EMBCD2064A

Related

Other Recalled Products